Skip to content

Clinical trials

Observational Lysosomal Storage Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Phase: Observational Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20063
20082
20092
20111
20122
20131
20141
20151
20161
20171
20181
20192
20203
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated6
Recruiting5
Unknown status4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
National Human Genome Research Institute (NHGRI)3
Lysosomal and Rare Disorders Research and Treatment Center, Inc.2
National Institute of Neurological Disorders and Stroke (NINDS)2
O & O Alpan LLC2
Shire2
Alexion Pharmaceuticals, Inc.1
Amicus Therapeutics1
Azafaros B.V.1
Baylor Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases31
Gaucher Disease8
Genetic Diseases, Inborn6
Metabolism, Inborn Errors6
Gangliosidosis, GM14
Metabolic Diseases4
Brain Diseases, Metabolic, Inborn3
Demyelinating Diseases3
Fabry Disease3
Glycogen Storage Disease Type II3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.